Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001616543/000110465925100097/tm2528782d1_8k.htm
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...
Senseonics stock drops on reverse split announcement despite record U.S. patient growth and 91% jump in Q3 revenue.
Preliminary unaudited revenue of $8.1 million for Q3 2025Generated record quarterly new patient starts in Q3 2025Established re...
Senseonics continues to expect full-year 2025 global net revenue to be approximately $34-38 million as we continue to roll out ...
CGM commercial operations to transition from Ascensia Diabetes Care to SenseonicsBrian Hansen to be appointed Chief Commercial ...
